Article | January 9, 2024

Factors In Developing Injectable Drug Placebo Formulations For Pharmaceutical Clinical Trials

Source: Singota Solutions

By Ryan Memmer and William Powers, Singota

Vaccine injectable vials and syringe GettyImages-1252804942

Designed and conducted properly, placebo-controlled clinical trials can provide proof a new drug is effective. Proper and complete understanding of development practices for placebos is important to the execution and outcomes of clinical trials. This article highlights factors that pharmaceutical scientists must consider when formulating placebos for injectable drugs to ensure the reliability and validity of clinical trial outcomes.

Injectable drug placebo formulation can be accomplished by leveraging knowledge of the active product and then developing specifications that clearly define and quantify these characteristics, along with appropriate analytical methods. Physical appearance and handling properties, such as viscosity, appearance, color, and pH, must be specified. Methods must be identified and developed/qualified prior to any product development/testing activities.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online